AriBioLab Co.,Ltd. (KOSDAQ:261780)

South Korea · Delayed Price · Currency is KRW

2,495.00

+85.00 (3.53%)

At close: Aug 11, 2026

AriBioLab Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	331.78	158.62	370.66	294.12	179.48	500
Revenue Growth	-	-57.21%	26.02%	63.87%	-64.10%	542.70%
Gross Profit	304.08	143.92	346.73	259.62	160.49	500
Operating Income	-13,575	-14,271	-7,696	-6,419	-6,469	-6,085
Net Income	-15,544	-16,044	-10,138	-1,749	-6,715	-18,420
Earnings Per Share	-578.52	-597.44	-378.00	-66.00	-254.00	-790.00
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	16,133	23,672	40,107	38,896	57,763	61,550
Total Debt	5,915	8,841	9,589	4,327	23,638	20,846
Net Cash (Debt)	10,218	14,831	30,518	34,569	34,125	40,704
Net Cash Growth	-62.95%	-51.40%	-11.72%	1.30%	-16.16%	579.94%
Net Cash Per Share	380.29	552.25	1137.84	1304.13	1290.78	1745.71

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-10,588	-11,017	-8,096	-5,293	-5,189	-4,740
Capital Expenditures	-36.1	-116.84	-179.21	-278.58	-447.4	-679.57
Free Cash Flow	-10,624	-11,134	-8,275	-5,572	-5,636	-5,419
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	91.65%	90.73%	93.55%	88.27%	89.42%	100.00%
Operating Margin	-4091.71%	-8997.23%	-2076.42%	-2182.53%	-3604.36%	-1216.93%
Pretax Margin	-4685.09%	-10115.30%	-2809.56%	-715.10%	-3741.36%	-3684.01%
Profit Margin	-4685.09%	-10115.30%	-2735.23%	-594.82%	-3741.36%	-3684.01%
FCF Margin	-3202.26%	-7019.41%	-2232.46%	-1894.38%	-3140.08%	-1083.83%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	210.67	478.48	221.45	513.51	734.04	586.73